Please wait...
175
21
Offers Claimed: 79
Downloaded Today: 63
Don’t see your pharmacy listed? Most pharmacies accept our discounts, so have your pharmacist enter this coupon to see if you will save money:
Note: This document contains side effect information about vardenafil. Some of the dosage forms listed on this page may not apply to the brand name Staxyn.
In SummaryCommon side effects of Staxyn include: headache and flushing. Other side effects include: dyspepsia and rhinitis. See below for a comprehensive list of adverse effects.
For the ConsumerApplies to vardenafil: oral tablet, oral tablet disintegrating
Along with its needed effects, vardenafil (the active ingredient contained in Staxyn) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking vardenafil:
Less common
Incidence not known
Some side effects of vardenafil may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
More common
Less common
For Healthcare Professionals
Applies to vardenafil: oral tablet, oral tablet disintegrating
GeneralThe most commonly reported adverse reaction is headache.
CardiovascularVery common (10% or more): Flushing (11%)
Common (1% to 10%): Palpitation, tachycardia, angina pectoris, myocardial infarction, ventricular tachyarrhythmias, hypotension
Rare (less than 0.1%): Hypertension
Postmarketing reports: Serious cerebrovascular hemorrhage, sudden cardiac death, transient ischemic attack, unstable angina and ventricular arrhythmia have been reported in temporal association with another medicinal product in this class.
Nervous systemVery common (10% or more): Headache (15%)
Common (1% to 10%): Dizziness, paresthesia and dysesthesia, somnolence, sleep disorder, syncope, amnesia, seizure
Postmarketing reports: Seizure, seizure recurrence, transient global amnesia
DermatologicCommon (1% to 10%): Erythema, rash, angioedema, allergic edema
Rare (less than 0.1%): Photosensitivity reaction
GastrointestinalCommon (1% to 10%): Dyspepsia, nausea, gastrointestinal and abdominal pain, dry mouth, diarrhea, gastroesophageal reflux disease, gastritis, vomiting
GenitourinaryUncommon (0.1% to 1%): Increase in erection
Rare (less than 0.1%): Priapism
Postmarketing reports: Penile hemorrhage, hematospermia
HepaticCommon (1% to 10%): Increase in transaminases
Rare (less than 0.1%) Increase in gamma-glutamyl-transferase
HypersensitivityCommon (1% to 10%): Allergic reactions
MusculoskeletalCommon (1% to 10%): Back pain, increase in creatine phosphokinase (CPK), increased muscle tone and cramping, myalgia
OcularCommon (1% to 10%): Visual disturbance, ocular hyperemia, visual color distortions, eye pain and eye discomfort, photophobia, increase in intraocular pressure, conjunctivitis
Rare (less than 0.1%): Increased lacrimation
Postmarketing reports: Non-arteritic anterior ischemic optic neuropathy (NAION), visual disturbances including vision loss (temporary or permanent), such as visual field defect, retinal vein occlusion, and reduced visual acuity.
Non-arteritic anterior ischemic optic neuropathy (NAION), a cause of decreased vision including permanent loss of vision, has been reported rarely postmarketing in temporal association with the use of phosphodiesterase type 5 (PDE5) inhibitors, including vardenafil.
OtherCommon (1% to 10%): Accidental injury, flu syndrome, tinnitus, vertigo, chest pain, feeling unwell
Postmarketing reports: Cases of sudden decrease or loss of hearing in temporal association with the use of PDE5 inhibitors, including this drug
RenalCommon (1% to 10%): Increased creatinine kinase
Postmarketing reports: Hematuria
RespiratoryCommon (1% to 10%): Rhinitis, sinusitis, dyspnea, sinus congestion, nasal congestion
Rare (less than 0.1%): Epistaxis
Medically reviewed by USARx EDITORIAL TEAM Last updated on 1/3/2022.
Source: Drugs.com Staxyn (www.drugs.com/staxyn.html).
July 22, 2021
February 3, 2021
February 2, 2021
February 5, 2021
May 23, 2022
May 23, 2022